Buy Now: Market Research
Dallas, TX: SandlerResearch announce Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Market Research Report in its Store
GlobalData, the industry analysis specialist, has released its new report, “Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global PAD market. The report identifies the key trends shaping and driving the global PAD market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global PAD sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
The global PAD therapeutics market accounted for approximately $606m in 2009. In 2001, the market was valued at $405m and it grew at an approximate CAGR of 5.2% between 2001 and 2009. The global PAD therapeutics market is expected to reach $1 billion by 2017 growing at a CAGR of 6.5% between 2009 and 2017. The primary factor contributing to the increase in growth over the forecast period is the increase in disease incidence and the launch of new first-in-class drugs. Presently the therapeutic regimen for PAD consists of antiplatelet agents such as clopidogrel (Plavix) and ticlopidine (Ticlid). Blood thinners such as pentoxifyline (Trental) and Cilostazol (Pletal) are also prescribed. Like most cardiovascular complications, aspirin is used as a complementary drug in combination with the above mentioned drug
Browse complete report : Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017
Scope
The report provides information on the key drivers and challenges of the PAD market. Its scope includes:
· Annualized global PAD market revenues data from 2001 to 2009, forecast for eight years to 2017.
· Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as of gene therapy, stem cell therapy, platelet aggregation inhibitor, Hydroxymethylglutaryl-CoA reductase inhibitor, monoclonal antibody, micro RNA, protein kinase modulator, Y2 agonist, and PPAR (Peroxisome Proliferator Activated Receptor) agonist.
· Analysis of the current and future competition in the global PAD market. Key market players covered are Sanofi Aventis, Indigo pharmaceuticals, BioMarin Pharmaceutical, and AnGes MG Inc.
· Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
· Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the PAD therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
· Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
· Develop business strategies by understanding the trends shaping and driving the global PAD market.
· Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global PAD market in future.
· Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
· Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
· Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
· What’s the next big thing in the global PAD market landscape? – Identify, understand and capitalize.
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 PAD Therapeutics Market: Introduction 5
2.1 Overview 5
2.2 GlobalData Pipeline Report Guidance 6
3 PAD Therapeutics Market: Market Characterization 7
3.1 PAD Therapeutics Market Size 7
3.2 PAD Therapeutics Market Forecast and CAGR 8
3.3 Drivers and Barriers for the PAD Therapeutics Market 9
3.3.1 Drivers for the PAD Therapeutics Market 9
3.3.2 Barriers for the PAD Therapeutics Market 9
3.4 Opportunity and Unmet Need 10
3.5 Key Takeaway 11
4 PAD Therapeutics Market: Competitive Assessment 12
4.1 Overview 12
4.2 Strategic Competitor Assessment 12
4.3 Product Portfolio for Major Marketed Products in the PAD Therapeutics Market 13
4.3.1 Plavix (Clopidogrel) 13
4.3.2 Pletal (Cilostazol) 14
4.3.3 Trental (pentoxifylline) 15
4.3.4 Ticlid (ticlopidine) 15
4.4 Key Takeaway 16
5 PAD Therapeutics Market: Pipeline Assessment 17
5.1 Overview 17
5.2 Strategic Pipeline Assessment 17
5.2.1 Technology Trends Analytical Framework 17
5.3 PAD Therapeutics – Promising Drugs under Clinical Development 18
5.4 Molecule Profiles for Promising Drugs Under Clinical Development 19
5.4.1 Collategene 19
5.4.2 NV1FGF 19
5.4.3 INDI-702 20
5.5 PAD Therapeutics Market – Pipeline Assessment by Mechanism of Action 21
5.6 PAD Therapeutics Market – Pipeline Assessment by Clinical Phases of Development 22
5.6.1 PAD Therapeutics – Phase III Clinical Pipeline 22
5.6.2 PAD Therapeutics – Phase II Clinical Pipeline 23
5.6.3 PAD Therapeutics – Phase I Clinical Pipeline 23
5.6.4 PAD Therapeutics – Preclinical Pipeline 24
5.6.5 PAD Therapeutics – Discovery Clinical Pipeline 24
5.7 Key Takeaway 24
6 PAD Therapeutics Market: Implications for Future Market Competition 25
7 PAD Therapeutics Market: Key Players in the PAD Therapeutics Market 26
7.1 Sanofi-Aventis 26
7.1.1 Overview 26
7.1.2 Financial Performance 27
7.1.3 Business Description 27
7.1.4 Cardiovascular Pipeline Portfolio 29
7.1.5 PAD Pipeline Portfolio 29
7.2 Indigo Pharmaceuticals 29
7.2.1 Overview 29
7.2.2 PAD Pipeline Portfolio 29
7.3 BioMarin Pharmaceutical 30
7.3.1 Overview 30
7.3.2 Financial Performance 30
7.3.3 Business Description 30
7.3.4 PAD Pipeline Portfolio 31
7.4 AnGes MG, Inc. 31
7.4.1 Overview 31
7.4.2 Financial Performance 31
7.4.3 Business Description 31
8 PAD Therapeutics Market: Appendix 33
8.1 Definitions 33
8.2 Scope of Pipeline Research 33
8.3 Acronyms 33
8.4 Research Methodology 34
8.4.1 Coverage 34
8.4.2 Secondary Research 35
8.4.3 Forecasting 35
8.4.4 Primary Research 38
8.4.5 Expert Panel Validation 38
8.5 Contact Us 38
8.6 Disclaimer 38
8.7 Sources 39
Related Reports:
About Us:
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.
Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.
We also provide 24/7 online and offline support to our customers
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
